Indian academy recommends whole cell pertussis vaccine for primary vaccination
Travasso, C.
Bmj 347: F7059
2013
ISSN/ISBN: 0959-8138 PMID: 24277630 Document Number: 666253
Document emailed within 1 workday
Related Documents
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Lim, F.Seng.; Han, H-Htay.; Jacquet, J-Marie.; Bock, H.L. 2007: Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine Annals of the Academy of Medicine Singapore 36(10): 801-806
1991: American Academy of Pediatrics Committee on Infectious Diseases: The relationship between pertussis vaccine and brain damage: reassessment Pediatrics 88(2): 397-400
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Visser, H.K. 2004: Health Council of the Netherlands advisory report 'Vaccination against pertussis'--time for a new vaccine Nederlands Tijdschrift Voor Geneeskunde 148(19): 916-918
Bose, A.; Dubey, A.P.; Gandhi, D.; Pandit, A.; Raghu, M.B.; Raghupathy, P.; Rao, M.I.S.; Verghese, V.P.; Datta, S.K.; Bock, H.L. 2007: Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children Indian Pediatrics 44(6): 421-424
Vodicková, M.; Svandová, E. 1986: Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis Ceskoslovenska Pediatrie 41(6): 321-323
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Zepp, F.; Knuf, M.; Habermehl, P.; Schmitt, H.J.; Meyer, C.; Clemens, R.; Slaoui, M. 1997: Cell-mediated immunity after pertussis vaccination and after natural infection Developments in Biological Standardization 89: 307-314
Bonin, C.R.B.; Fernandes, G.C.ôr.; de Menezes Martins, R.; Camacho, L.A.B.; Teixeira-Carvalho, A.éa.; da Mota, L.M.H.; de Lima, S.M.B.; Campi-Azevedo, A.C.; Martins-Filho, O.A.; Dos Santos, R.W.; Lobosco, M. 2020: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals Bmc Bioinformatics 21(Suppl 17): 551
Deloria, M.A.; Blackwelder, W.C.; Decker, M.D.; Englund, J.A.; Steinhoff, M.C.; Pichichero, M.E.; Rennels, M.B.; Anderson, E.L.; Edwards, K.M. 1995: Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations Pediatrics 96(3 Pt 2): 592-594
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
De Wildt, D.J.; de Jong, Y.; Nijkamp, F.P.; Kreeftenberg, J.G. 1985: Pharmacological evaluation of purified component and whole-cell pertussis vaccine in the cardiovascular system of rats Journal of Pharmacology and Experimental Therapeutics 232(2): 541-544
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41